TRPV4’s participation has also been investigated in different preclinical models of pain and nociception induced by inflammatory and neuropathic pain [73,83,104,105,106,107], and this receptor was implicated as a contributor to the etiology of chemotherapy-induced peripheral neuropathy [59,106]. The gene discussed is TRPV4; the disease is peripheral neuropathy.